vs

Side-by-side financial comparison of Instil Bio, Inc. (TIL) and Beyond Air, Inc. (XAIR). Click either name above to swap in a different company.

Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $2.2M, roughly 1.0× Beyond Air, Inc.). Beyond Air, Inc. runs the higher net margin — -334.4% vs -365.3%, a 31.0% gap on every dollar of revenue. On growth, Beyond Air, Inc. posted the faster year-over-year revenue change (104.7% vs -19.2%).

Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.

Delta Air Lines, Inc. is a major airline in the United States headquartered in Atlanta, Georgia, operating nine hubs, with Hartsfield–Jackson Atlanta International Airport being its largest in terms of total passengers and number of departures. With its regional subsidiaries and contractors operating under the brand name Delta Connection, Delta has over 5,400 flights daily and serves 325 destinations in 52 countries on six continents.

TIL vs XAIR — Head-to-Head

Bigger by revenue
TIL
TIL
1.0× larger
TIL
$2.2M
$2.2M
XAIR
Growing faster (revenue YoY)
XAIR
XAIR
+123.8% gap
XAIR
104.7%
-19.2%
TIL
Higher net margin
XAIR
XAIR
31.0% more per $
XAIR
-334.4%
-365.3%
TIL

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
TIL
TIL
XAIR
XAIR
Revenue
$2.2M
$2.2M
Net Profit
$-8.2M
$-7.3M
Gross Margin
13.7%
Operating Margin
-426.3%
-300.6%
Net Margin
-365.3%
-334.4%
Revenue YoY
-19.2%
104.7%
Net Profit YoY
31.1%
43.7%
EPS (diluted)
$-1.13
$-0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TIL
TIL
XAIR
XAIR
Q4 25
$2.2M
$2.2M
Q3 25
$2.2M
$1.8M
Q2 25
$2.2M
$1.8M
Q1 25
$2.2M
$1.2M
Q4 24
$2.8M
$1.1M
Q3 24
$1.5M
$798.0K
Q2 24
$0
$683.0K
Q1 24
$0
$470.0K
Net Profit
TIL
TIL
XAIR
XAIR
Q4 25
$-8.2M
$-7.3M
Q3 25
$-13.6M
$-7.9M
Q2 25
$-21.4M
$-7.7M
Q1 25
$-28.2M
$-8.0M
Q4 24
$-11.9M
$-13.0M
Q3 24
$-23.0M
$-13.4M
Q2 24
$-14.9M
$-12.2M
Q1 24
$-24.3M
$-13.7M
Gross Margin
TIL
TIL
XAIR
XAIR
Q4 25
13.7%
Q3 25
-16.4%
Q2 25
8.9%
Q1 25
-2.8%
Q4 24
-20.1%
Q3 24
-135.8%
Q2 24
-48.6%
Q1 24
-109.4%
Operating Margin
TIL
TIL
XAIR
XAIR
Q4 25
-426.3%
-300.6%
Q3 25
-670.0%
-421.4%
Q2 25
-1045.5%
-432.8%
Q1 25
-1363.2%
-622.6%
Q4 24
-426.1%
-1021.6%
Q3 24
-1582.8%
-1608.1%
Q2 24
-1988.3%
Q1 24
-2687.9%
Net Margin
TIL
TIL
XAIR
XAIR
Q4 25
-365.3%
-334.4%
Q3 25
-606.0%
-436.7%
Q2 25
-954.2%
-437.0%
Q1 25
-1257.8%
-697.4%
Q4 24
-428.8%
-1215.7%
Q3 24
-1541.9%
-1673.9%
Q2 24
-1786.4%
Q1 24
-2916.4%
EPS (diluted)
TIL
TIL
XAIR
XAIR
Q4 25
$-1.13
$-0.85
Q3 25
$-2.01
$-1.25
Q2 25
$-3.24
$-1.53
Q1 25
$-4.32
$13.26
Q4 24
$-1.82
$-2.96
Q3 24
$-3.54
$-5.67
Q2 24
$-2.29
$-5.32
Q1 24
$-3.74
$-0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TIL
TIL
XAIR
XAIR
Cash + ST InvestmentsLiquidity on hand
$6.6M
$11.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$113.9M
$8.1M
Total Assets
$203.5M
$36.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TIL
TIL
XAIR
XAIR
Q4 25
$6.6M
$11.7M
Q3 25
$5.8M
$10.7M
Q2 25
$7.7M
$6.5M
Q1 25
$15.4M
$6.9M
Q4 24
$8.8M
$10.9M
Q3 24
$6.7M
$28.4M
Q2 24
$6.8M
$21.4M
Q1 24
$5.5M
$34.5M
Total Debt
TIL
TIL
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$11.8M
Q3 24
$12.5M
Q2 24
$17.5M
Q1 24
$17.5M
Stockholders' Equity
TIL
TIL
XAIR
XAIR
Q4 25
$113.9M
$8.1M
Q3 25
$120.4M
$12.7M
Q2 25
$131.7M
$9.9M
Q1 25
$144.9M
$13.6M
Q4 24
$169.4M
$17.6M
Q3 24
$176.3M
$28.1M
Q2 24
$195.0M
$16.1M
Q1 24
$205.8M
$25.0M
Total Assets
TIL
TIL
XAIR
XAIR
Q4 25
$203.5M
$36.8M
Q3 25
$211.8M
$31.0M
Q2 25
$231.0M
$28.1M
Q1 25
$237.4M
$30.1M
Q4 24
$263.6M
$34.1M
Q3 24
$272.6M
$53.0M
Q2 24
$294.3M
$46.5M
Q1 24
$306.3M
$57.0M
Debt / Equity
TIL
TIL
XAIR
XAIR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.67×
Q3 24
0.44×
Q2 24
1.08×
Q1 24
0.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TIL
TIL
XAIR
XAIR
Operating Cash FlowLast quarter
$-7.1M
$-4.2M
Free Cash FlowOCF − Capex
$-4.3M
FCF MarginFCF / Revenue
-193.8%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-22.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TIL
TIL
XAIR
XAIR
Q4 25
$-7.1M
$-4.2M
Q3 25
$-10.6M
$-4.5M
Q2 25
$-14.8M
$-4.5M
Q1 25
$-4.2M
$-7.0M
Q4 24
$-10.6M
$-7.7M
Q3 24
$-20.1M
$-13.3M
Q2 24
$-10.6M
$-10.2M
Q1 24
$-14.4M
$-10.7M
Free Cash Flow
TIL
TIL
XAIR
XAIR
Q4 25
$-4.3M
Q3 25
$-4.7M
Q2 25
$-4.7M
Q1 25
$-8.5M
Q4 24
$-8.3M
Q3 24
$-14.5M
Q2 24
$-12.9M
Q1 24
$-12.7M
FCF Margin
TIL
TIL
XAIR
XAIR
Q4 25
-193.8%
Q3 25
-258.5%
Q2 25
-268.4%
Q1 25
-733.9%
Q4 24
-771.5%
Q3 24
-1819.9%
Q2 24
-1881.8%
Q1 24
-2692.8%
Capex Intensity
TIL
TIL
XAIR
XAIR
Q4 25
1.5%
Q3 25
13.5%
Q2 25
11.3%
Q1 25
130.0%
Q4 24
0.0%
50.1%
Q3 24
0.0%
147.2%
Q2 24
391.4%
Q1 24
410.9%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons